Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA

This study is ongoing, but not recruiting participants.

Study NCT00254293 Information provided by Bristol-Myers Squibb

First Received: November 15, 2005 Last Updated: September 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2012
Estimated Primary Completion Date:	January 2012 (Final data collection date for primary outcome measure)